| 产品名称： | Xanthophyllomyces dendrorhous Golubev |
|---|---|
| 商品货号： | TS147711 |
| Deposited As： | Phaffia rhodozyma Miller et al., anamorph |
| Strain Designations： | Ant-1-4 IGI887J2 |
| Synonym： | Phaffia rhodozyma Miller et al. |
| Application： | produces astaxanthin |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Type Strain： | no |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Medium： | ATCC® Medium 200: YM agar or YM broth |
| Growth Conditions： | Temperature: 24.0°C |
| Name of Depositor： | EA Johnson |
| U.S. Patent Number： | |
| Chain of Custody： | ATCC < |
| Isolation： | mutant derived from ATCC 66270 |
| References： | An GH, et al. Isolation of Phaffia rhodozyma mutants with increased astaxanthin content. Appl. Environ. Microbiol. 55: 116-124, 1989. Schreiber D, et al. Processes for in vivo production of astaxanthin and Phaffia rhodozyma yeast of enhanced astaxanthin content. US Patent 5,182,208 dated Jan 26 1993 Johnson EA, et al. Processes for in vivo production of astaxanthin and Phaffia rhodozyma yeast of enhanced astaxanthin content. US Patent 5,356,809 dated Oct 18 1994 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Xanthophyllomyces dendrorhous Golubev |
|---|---|
| 商品货号： | TS147711 |
| Deposited As： | Phaffia rhodozyma Miller et al., anamorph |
| Strain Designations： | Ant-1-4 IGI887J2 |
| Synonym： | Phaffia rhodozyma Miller et al. |
| Application： | produces astaxanthin |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Type Strain： | no |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Medium： | ATCC® Medium 200: YM agar or YM broth |
| Growth Conditions： | Temperature: 24.0°C |
| Name of Depositor： | EA Johnson |
| U.S. Patent Number： | |
| Chain of Custody： | ATCC < |
| Isolation： | mutant derived from ATCC 66270 |
| References： | An GH, et al. Isolation of Phaffia rhodozyma mutants with increased astaxanthin content. Appl. Environ. Microbiol. 55: 116-124, 1989. Schreiber D, et al. Processes for in vivo production of astaxanthin and Phaffia rhodozyma yeast of enhanced astaxanthin content. US Patent 5,182,208 dated Jan 26 1993 Johnson EA, et al. Processes for in vivo production of astaxanthin and Phaffia rhodozyma yeast of enhanced astaxanthin content. US Patent 5,356,809 dated Oct 18 1994 |
